Log In
BCIQ
Print this Print this
 

GBR 900 (formerly BXL1H5)

Also known as: formerly MNAC13

  Manage Alerts
Collapse Summary General Information
Company Lay Line Genomics S.p.A.
DescriptionHumanized mAb TrkA receptor
Molecular Target Neurotrophic tyrosine kinase receptor 1 (TrkA) (NTRK1)
Mechanism of ActionTrkA agonist; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation
PartnerGlenmark Pharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$41.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/22/2010

Undisclosed

Undisclosed

Undisclosed

02/15/2010

$41.0M

Undisclosed

0

Get a free BioCentury trial today